Back to top
Top
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

DERep Home Page

["Patient Characteristic, Race": "Race"]

Performance/Reporting Period
2022
Value Set Description from VSAC
Clinical Focus: n/a Data Element Scope: n/a Inclusion Criteria: n/a Exclusion Criteria: n/a

Constrained to codes in the Patient Characteristic, Race: Race value set (2.16.840.1.114222.4.11.836)

QDM Datatype and Definition

"Patient Characteristic, Race"

Data elements that meet criteria using this datatype should document the patient’s race.

Timing: Race does not have a specific timing. Measures using "Patient Characteristic, Race" should address the most recent entry in the clinical record.

eCQMs using this data element:
CMS133v10 - Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
CMS142v10 - Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
CMS117v10 - Childhood Immunization Status
CMS105v10 - Discharged on Statin Medication
CMS349v4 - HIV Screening
CMS645v5 - Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
CMS249v4 - Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture
CMS71v11 - Anticoagulation Therapy for Atrial Fibrillation or Flutter
CMS131v10 - Diabetes: Eye Exam
CMS90v11 - Functional Status Assessments for Heart Failure
CMS75v10 - Children Who Have Dental Decay or Cavities
CMS111v10 - Median Admit Decision Time to ED Departure Time for Admitted Patients
CMS156v10 - Use of High-Risk Medications in Older Adults
CMS135v10 - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS139v10 - Falls: Screening for Future Fall Risk
CMS144v10 - Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
CMS127v10 - Pneumococcal Vaccination Status for Older Adults
CMS129v11 - Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
CMS506v4 - Safe Use of Opioids - Concurrent Prescribing
CMS125v10 - Breast Cancer Screening
CMS146v10 - Appropriate Testing for Pharyngitis
CMS137v10 - Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
CMS154v10 - Appropriate Treatment for Upper Respiratory Infection (URI)
CMS22v10 - Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
CMS2v11 - Preventive Care and Screening: Screening for Depression and Follow-Up Plan
CMS69v10 - Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
CMS646v2 - Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer
CMS56v10 - Functional Status Assessment for Total Hip Replacement
CMS72v10 - Antithrombotic Therapy By End of Hospital Day 2
CMS108v10 - Venous Thromboembolism Prophylaxis
CMS104v10 - Discharged on Antithrombotic Therapy
CMS143v10 - Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
CMS771v3 - Urinary Symptom Score Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia
CMS165v10 - Controlling High Blood Pressure
CMS177v10 - Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS122v10 - Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)
CMS130v10 - Colorectal Cancer Screening
CMS153v10 - Chlamydia Screening for Women
CMS9v10 - Exclusive Breast Milk Feeding
CMS149v10 - Dementia: Cognitive Assessment
CMS134v10 - Diabetes: Medical Attention for Nephropathy
CMS157v10 - Oncology: Medical and Radiation - Pain Intensity Quantified
CMS529v2 - Core Clinical Data Elements for the Hybrid Hospital-Wide Readmission (HWR) Measure with Claims and Electronic Health Record Data
CMS145v10 - Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than 40%)
CMS138v10 - Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
CMS161v10 - Adult Major Depressive Disorder (MDD): Suicide Risk Assessment
CMS66v10 - Functional Status Assessment for Total Knee Replacement
CMS50v10 - Closing the Referral Loop: Receipt of Specialist Report
CMS74v11 - Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists
CMS68v11 - Documentation of Current Medications in the Medical Record
CMS190v10 - Intensive Care Unit Venous Thromboembolism Prophylaxis
CMS159v10 - Depression Remission at Twelve Months
CMS124v10 - Cervical Cancer Screening
CMS155v10 - Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents
CMS128v10 - Anti-depressant Medication Management
CMS136v11 - Follow-Up Care for Children Prescribed ADHD Medication (ADD)
CMS347v5 - Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
CMS147v11 - Preventive Care and Screening: Influenza Immunization
Last Updated: Jul 08, 2021

We want your feedback

Feedback pertains to:
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.